Most Recent
Inhibox maker used Allergan’s Botox trade mark for comparison’s sake, court hears
Intellectual Property 2018-09-05 8:30 pm By Miklos Bolza

The company that manufactures Botox alternatives has denied infringing on Allergan’s Botox trade mark, telling a court Wednesday its use of the word was for comparative purposes only.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Aldi offered $150,000 to settle MoroccanOil dispute
Competition & Consumer Protection 2018-09-04 11:34 pm By Cat Fredenburgh

Discount supermarket chain Aldi offered $150,000 to end a lawsuit brought by the maker of the popular MoroccanOil line of hair products, a court judgment revealed Tuesday.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

ObjectiVision wraps up IP trial against University of Sydney
Intellectual Property 2018-09-04 10:25 pm By Miklos Bolza

Ophthalmic diagnostic device manufacturer ObjectiVision has made its final pitch to the Federal Court at the end of trial in a long-running intellectual property and contract dispute with the University of Sydney, saying in closing submissions that the school had run a “curious” case. 

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Microsoft wins $2.8M judgment for violations of Windows IP
Intellectual Property 2018-09-04 5:17 pm By Cat Fredenburgh

Microsoft has won a $2.8 million judgment against a Melbourne computer retailer for violating the intellectual property for its Windows 7 software.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Hytera ordered to hand over source code in Motorola IP dispute
Intellectual Property 2018-08-30 9:41 pm By Miklos Bolza

Chinese tech company Hytera Communications Corporation has been ordered to hand over source code for all radio devices at the heart of a international patent dispute with Motorola Solutions.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Alphapharm says Sanofi patent amendment should doom injunction bid
Intellectual Property 2018-08-30 9:13 pm By Miklos Bolza

Generic drug maker Alphapharm is fighting a bid by global pharmaceutical giant Sanofi-Aventis to block the listing of one of its injector pens, saying the proposed injunction should be denied because Sanofi is seeking to amend the patent at issue.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Fonterra denied strict confidentiality regime in Bega trade mark dispute
Intellectual Property 2018-08-29 9:33 pm By Cat Fredenburgh

A judge has denied a bid for a strict regime for dealing with confidential information in a lawsuit between cheese giants Fonterra and Bega over alleged violations of the terms of a trade mark licensing agreement.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Apotex threatened to infringe Cialis patents, court finds
Intellectual Property 2018-08-27 11:09 pm By Cat Fredenburgh

A judge has found two patents held by an Eli Lilly & Co. unit for erectile dysfunction drug Cialis are valid and that generic manufacturer Apotex threatened to infringe the patents.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Millennium wins injunction against Juno over generic cancer drug
Intellectual Property 2018-08-27 11:27 am By Christine Caulfield

US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.

Dr. Reddy’s slams Millennium’s injunction bid in cancer drug case
Intellectual Property 2018-08-23 5:41 pm By Miklos Bolza

An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy’s Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?

Lost your password?

Contact us to enquire about group subscriptions.